The Role of Endocannabinoids in Insulin Production and Action
|ClinicalTrials.gov Identifier: NCT01517100|
Recruitment Status : Completed
First Posted : January 25, 2012
Last Update Posted : April 5, 2018
National Institute on Aging (NIA)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute on Aging (NIA) )
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||October 6, 2014|
|Actual Study Completion Date :||October 6, 2014|
Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia. 2001 Aug;44(8):929-45. Review.
Straub SG, Sharp GW. Hypothesis: one rate-limiting step controls the magnitude of both phases of glucose-stimulated insulin secretion. Am J Physiol Cell Physiol. 2004 Sep;287(3):C565-71. Review.